Background: Poorly controlled hypertension may lead to several serious health problems, including stroke, aneurysms, coronary artery disease, kidney disease and peripheral artery disease. Objectives: This study aimed at exploring the magnitude of the problem of non-compliance with antihypertensive drugs among patients in Saudi Arabia and identifying the associated factors. Subjects and Methods: a cross-sectional study was carried out during the period January to August 2018 through social media sites including a sample of adult patients from different regions of the kingdom (Saudi and none-Saudi). Data were collected online through a questionnaire. The questionnaire included socio-demographic characteristics of hypertensive patients, history of smoking, and hypertension-related history. Adherence of patients to anti- hypertensive drugs was assessed utilizing an 8-item modified Morisky Medication Adherence Scale (8-MMMAS). Results: The study included 267 hypertensive patients. About half of them (48.5%) aged over 50 years. More than half were females (58%), high educated (62.3%) and employed (46.7%). Approaching half of them, 42% has health insurance and 6 years or more of hypertension (47.6%). About two-thirds of them (68.8%) reported history of taking between one and three drugs/day and one dose of antihypertensive medication/day (64.8%). High level of compliance with anti-hypertensive medications was observed among 6.2% of patients whereas medium and low levels were observed among 67.4% and 26.4% of them. High level of compliance was reported among patients aged over 50 years (p<0.001), females (0.033), widowed (0.001) and those haven’t history of chronic diseases (p<0.001). Conclusion: high compliance to anti-hypertensive medications in Saudi Arabia is low, particularly among male and young patients.
Alotayfi, M. J. Y., Alsohaimi, S. A., AL-Qadi, B. K., Kamil, S. M., Aththi, A. J. H., Alhazmi, G. A. A., Qasem, H. A. O., & Bugis, A. A. (2018). Poor Compliance to Anti-Hypertensive Drugs in Saudi Arabia. The Egyptian Journal of Hospital Medicine, 73(5), 6696-6701. doi: 10.21608/ejhm.2018.16015
MLA
Mohsen Jaber Yahya Alotayfi; Salem Abdullah Alsohaimi; Bushra Khalid AL-Qadi; Salma Mosa Kamil; Alaa Jabril H Aththi; Ghalia Alhussain Ahmed Alhazmi; Halima Ahmed Othman Qasem; Amjad Ahmed Bugis. "Poor Compliance to Anti-Hypertensive Drugs in Saudi Arabia", The Egyptian Journal of Hospital Medicine, 73, 5, 2018, 6696-6701. doi: 10.21608/ejhm.2018.16015
HARVARD
Alotayfi, M. J. Y., Alsohaimi, S. A., AL-Qadi, B. K., Kamil, S. M., Aththi, A. J. H., Alhazmi, G. A. A., Qasem, H. A. O., Bugis, A. A. (2018). 'Poor Compliance to Anti-Hypertensive Drugs in Saudi Arabia', The Egyptian Journal of Hospital Medicine, 73(5), pp. 6696-6701. doi: 10.21608/ejhm.2018.16015
VANCOUVER
Alotayfi, M. J. Y., Alsohaimi, S. A., AL-Qadi, B. K., Kamil, S. M., Aththi, A. J. H., Alhazmi, G. A. A., Qasem, H. A. O., Bugis, A. A. Poor Compliance to Anti-Hypertensive Drugs in Saudi Arabia. The Egyptian Journal of Hospital Medicine, 2018; 73(5): 6696-6701. doi: 10.21608/ejhm.2018.16015
)
View on SCiNiTO